Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approval Number

国药准字H20253855

Company南京方生和医药科技有限公司

Registration Date

April 8, 2025

Drug Information

Generic Name

达格列净二甲双胍缓释片(Ⅰ)

Dosage Form

片剂

Strength

每片含达格列净10mg（按C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

April 8, 2025

Company Information

Applicant Company

Company Name南京方生和医药科技有限公司

Company Address

南京市浦口区浦口经济开发区百合路111号紫峰研创中心一期2栋

Manufacturing Company

Company Name以岭万洲国际制药有限公司

Company Address

河北省石家庄市高新区珠江大道36号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy